Mink Therapeutics Inc INKT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/10/24 EDT
0.90quote price arrow up+0.0007 (+0.0778%)
Volume
19,999
52 week range
0.75 - 3.34
Loading...
  • Open0.92
  • Day High0.92
  • Day Low0.89
  • Prev Close0.8993
  • 52 Week High3.34
  • 52 Week High Date06/22/23
  • 52 Week Low0.75
  • 52 Week Low Date01/16/24

Key Stats

  • Market Cap31.234M
  • Shares Out34.70M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.03
  • YTD % Change-15.89

KEY STATS

  • Open0.92
  • Day High0.92
  • Day Low0.89
  • Prev Close0.8993
  • 52 Week High3.34
  • 52 Week High Date06/22/23
  • 52 Week Low0.75
  • 52 Week Low Date01/16/24
  • Market Cap31.234M
  • Shares Out34.70M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.03
  • YTD % Change-15.89

RATIOS/PROFITABILITY

  • EPS (TTM)-0.65
  • P/E (TTM)-1.38
  • Fwd P/E (NTM)-1.59
  • EBITDA (TTM)-22.716M
  • ROE (TTM)-1,238.98%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/14/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mink Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells are a distinct T cell population that combine durable memory responses with the rapid cytolytic features of natural killer cells. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy...
Garo Armen Ph.D.
Chairman of the Board
Jennifer Buell Ph.D.
President, Chief Executive Officer, Director
Address
149 Fifth Avenue, Suite 500
New York, NY
10010
United States

Top Peers

SYMBOLLASTCHG%CHG
EFTR
eFFECTOR Therapeutics Inc
2.03-0.11-5.14%
ACXP
Acurx Pharmaceuticals Inc
2.03+0.01+0.50%
ACHL
Achilles Therapeutics PLC
0.935+0.0164+1.7853%
NGNE
Neurogene Inc
32.50-0.71-2.14%
IINN
Inspira Technologies Oxy BHN Ltd
2.00-0.08-3.85%